Repositorio Dspace

Treatment of Chronic Heart Failure in Advanced Chronic Kidney Disease: The HAKA Multicenter Retrospective Real-World Study

Mostrar el registro sencillo del ítem

dc.contributor.author Quiroga, Borja
dc.contributor.author Ortiz, Alberto
dc.contributor.author Núñez, Sara
dc.contributor.author Kislikova, María
dc.contributor.author González-Sanchidrian, Silvia
dc.contributor.author Broseta, José-Jesús
dc.contributor.author Albines, Zoila-Stany
dc.contributor.author Escamilla-Cabrera, Beatriz
dc.contributor.author Rivero-Viera, Yaiza
dc.contributor.author Rodríguez-Santarelli, David-P
dc.contributor.author Salanova-Villanueva, Laura
dc.contributor.author López-Rodríguez, Francisca
dc.contributor.author Cancho-Castellano, Bárbara
dc.contributor.author Ibáñez-Cerezon, María
dc.contributor.author Gutiérrez-Rivas, Carmen-Patricia
dc.contributor.author Areste, Nuria
dc.contributor.author Campos-Gutiérrez, Belén
dc.contributor.author Gálvez, Ana-Rodenas
dc.contributor.author Piza, María-Constanza-Glucksmann
dc.contributor.author Manzanos, Sagrario-Balda
dc.contributor.author Soldevila-Orient, Amparo
dc.contributor.author Gayo, Lucía-Rodríguez
dc.contributor.author Moral-Berrio, Esperanza
dc.contributor.author Díaz, Mayra-Ortega
dc.contributor.author Beltrán-Catalán, Sandra
dc.contributor.author García, Adriana-Puente
dc.contributor.author Rojas, Miguel-Ángel
dc.contributor.author Barrios, RHaridian-Sosa
dc.contributor.author Santana-Zapatero, Henar
dc.contributor.author Rangel-Hidalgo, Gema
dc.contributor.author Martínez-Canet, Ana-María
dc.contributor.author Díez, Javier
dc.date.accessioned 2025-11-20T07:12:56Z
dc.date.available 2025-11-20T07:12:56Z
dc.date.issued 2024
dc.identifier.citation Quiroga B, Ortiz A, Núñez S, Kislikova M, González Sanchidrián S, Broseta JJ, et al. Treatment of chronic heart failure in advanced chronic kidney disease: the HAKA multicenter retrospective real-world study. Cardiorenal Med [Internet]. 3 de abril de 2024 [citado 19 de noviembre de 2025]; Disponible en: https://karger.com/article/doi/10.1159/000538030
dc.identifier.issn 1664-3828
dc.identifier.uri https://sms.carm.es/ricsmur/handle/123456789/21429
dc.description.abstract INTRODUCTION: Chronic heart failure (HF) has high rates of mortality and hospitalization in patients with advanced chronic kidney disease (aCKD). However, randomized clinical trials have systematically excluded aCKD population. We have investigated current HF therapy in patients receiving clinical care in specialized aCKD units. METHODS: The Heart And Kidney Audit (HAKA) was a cross-sectional and retrospective real-world study including outpatients with aCKD and HF from 29 Spanish centers. The objective was to evaluate how the treatment of HF in patients with aCKD complied with the recommendations of the European Society of Cardiology Guidelines for the diagnosis and treatment of HF, especially regarding the foundational drugs: renin-angiotensin system inhibitors (RASi), angiotensin receptor blocker/neprilysin inhibitors (ARNI), beta-blockers (BBs), mineralocorticoid receptor antagonists (MRAs), and sodium-glucose cotransporter-2 inhibitors (SGLT2i). RESULTS: Among 5,012 aCKD patients, 532 (13%) had a diagnosis of HF. Of them, 20% had reduced ejection fraction (HFrEF), 13% mildly reduced EF (HFmrEF), and 67% preserved EF (HFpEF). Only 9.3% of patients with HFrEF were receiving quadruple therapy with RASi/ARNI, BB, MRA, and SGLT2i, but the majority were not on the maximum recommended doses. None of the patients with HFrEF and CKD G5 received quadruple therapy. Among HFmrEF patients, approximately half and two-thirds were receiving RASi and/or BB, respectively, while less than 15% received ARNI, MRA, or SGLT2i. Less than 10% of patients with HFpEF were receiving SGLT2i. CONCLUSIONS: Under real-world conditions, HF in aCKD patients is sub-optimally treated. Increased awareness of current guidelines and pragmatic trials specifically enrolling these patients represent unmet medical needs.
dc.language.iso eng
dc.publisher KARGER
dc.rights https://creativecommons.org/licenses/by-nc/4.0/
dc.rights.uri Atribución/Reconocimiento-NoComercial 4.0 Internacional *
dc.subject.mesh Humans
dc.subject.mesh Heart Failure/complications/drug therapy/physiopathology
dc.subject.mesh Retrospective Studies
dc.subject.mesh Male
dc.subject.mesh Female
dc.subject.mesh Renal Insufficiency, Chronic/complications/physiopathology
dc.subject.mesh Aged
dc.subject.mesh Cross-Sectional Studies
dc.subject.mesh Mineralocorticoid Receptor Antagonists/therapeutic use
dc.subject.mesh Angiotensin Receptor Antagonists/therapeutic use
dc.subject.mesh Adrenergic beta-Antagonists/therapeutic use
dc.subject.mesh Sodium-Glucose Transporter 2 Inhibitors/therapeutic use
dc.subject.mesh Stroke Volume/physiology
dc.subject.mesh Middle Aged
dc.subject.mesh Spain/epidemiology
dc.subject.mesh Guideline Adherence
dc.subject.mesh Angiotensin-Converting Enzyme Inhibitors/therapeutic use
dc.subject.mesh Aged, 80 and over
dc.title Treatment of Chronic Heart Failure in Advanced Chronic Kidney Disease: The HAKA Multicenter Retrospective Real-World Study
dc.type info:eu-repo/semantics/article
dc.identifier.pmid 38513622
dc.relation.publisherversion https://karger.com/article/doi/10.1159/000538030
dc.identifier.doi 10.1159/000538030
dc.journal.title Cardiorenal Medicine
dc.identifier.essn 1664-5502


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Buscar en DSpace


Búsqueda avanzada

Listar

Mi cuenta